Preventive Care
- It’s a new year, looking back and looking forward
Reflections on highlights from 2023 and impending changes in 2024, along with some acknowledgments and farewells.
- Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting
Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.
- 2023 Update in ambulatory general internal medicine
Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.
- Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
Several new nonstatin medications have been approved in recent years, with robust data from clinical trials supporting their use in atherosclerotic disease.
- To prophylax or not to prophylax for endocarditis: Still a question
Give prophylactic antibiotics before invasive dental procedures? On the surface, it may seem sensible. But we have more to learn about the successful clearance of bacteria from the bloodstream and why protective mechanisms occasionally fail.
- Getting to the root of the problem: Should my patient receive antibiotics before dental procedures to prevent infective endocarditis?
Individual risk depends on inherent patient and procedural risk factors. The authors offer practical points to aid decision-making.
- Aspirin in primary prevention of cardiovascular events: Key questions remain
Are we done with the issue of aspirin in primary prevention? Not quite yet.